Efficacy and Cost Analysis for Acitretin for Basal and Squamous Cell Carcinoma Prophylaxis in Renal Transplant Recipients

被引:11
作者
Badri, Omar [1 ]
Schmults, Chrysalyne D. [1 ]
Karia, Pritesh S. [1 ,2 ]
Ruiz, Emily S. [1 ]
机构
[1] Harvard Med Sch, Dept Dermatol, Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
关键词
SKIN-CANCER;
D O I
10.1097/DSS.0000000000002423
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Supplemental Digital Content is Available in the Text.
引用
收藏
页码:125 / 126
页数:2
相关论文
共 5 条
[1]   PREVENTION OF SKIN-CANCER AND REDUCTION OF KERATOTIC SKIN-LESIONS DURING ACITRETIN THERAPY IN RENAL-TRANSPLANT RECIPIENTS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].
BAVINCK, JNB ;
TIEBEN, LM ;
VANDERWOUDE, FJ ;
TEGZESS, AM ;
HERMANS, J ;
TERSCHEGGET, J ;
VERMEER, BJ .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :1933-1938
[2]  
Beyer V, 2010, ARCH DERMATOL, V146, P46, DOI 10.1001/archdermatol.2009.319
[3]   Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients:: Clinical effects of a randomized trial comparing two doses of acitretin [J].
de Sévaux, RGL ;
Smit, JV ;
de Jong, EMGJ ;
van de Kerkhof, PCM ;
Hoitsma, AJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (03) :407-412
[4]  
George Renu, 2002, Australas J Dermatol, V43, P269
[5]  
McKenna DB, 1999, BRIT J DERMATOL, V140, P656